So long, Pap smears — HPV screening found to be better at cancer detection
21 September, 2017 by Lauren DavisResearchers have compared the effectiveness of human papillomavirus (HPV) testing to the common but somewhat unpopular practice of Pap tests, in what is said to be Australia's biggest clinical trial.
Paradigm receives ethics approval for osteoarthritis trial
21 September, 2017Paradigm Biopharmaceuticals has received ethics approval for its Phase 2b clinical trial to investigate pentosan polysulfate sodium (PPS) in subjects with knee osteoarthritis (OA) and bone marrow edema lesions (BMELs).
Personalised medicine trial for childhood cancers
19 September, 2017Personalised medicine for childhood cancers in Australia is now one step closer, following the launch of the Zero Childhood Cancer program's national clinical trial.
New spray dryer recovers 95% of particles, improves efficiency and cuts costs
14 September, 2017Chemical engineers at the University of Sydney have developed and tested a new pilot-scale spray drying system that is designed to recover more than 95% of particles.
Merck to co-lead global cancer big data alliance
12 September, 2017Merck is collaborating with independent not-for-profit Project Data Sphere to jointly lead the Global Oncology Big Data Alliance (GOBDA).
Caucasian ovarian cancer patients should stick to standard dosing, study finds
05 September, 2017European women with ovarian cancer should stick to the standard three-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to the results of the phase III ICON8 trial.
Stem cell therapy for Parkinson's disease
01 September, 2017 by Adam FloranceSufferers of Parkinson's disease may soon be enjoying improved movement thanks to a team of researchers from Kyoto University, Japan, and some crab-eating macaques.
Garvan launches Genomic Cancer Medicine Program for rare cancers
31 August, 2017In Australia, around 52,000 people will be diagnosed with rare and less common (RLC) cancers in 2017, according to estimates by Cancer in Australia 2017.
Australian specialists may hold key to ovarian cancer treatment
31 August, 2017Three Australian cancer treatment centres are involved in a drug trial that could see the next major advancement in ovarian cancer therapy.
Avita Medical hires Erin Liberto as CCO
31 August, 2017Medical device company Avita Medical has named Erin Liberto as the company's chief commercial officer.
Sniffing out Alzheimer's early
24 August, 2017 by Adam FloranceCanadian researchers have found that a simple smell test may help in diagnosing those at risk of developing Alzheimer's disease.
Stemina prepares to launch autism diagnostic product
24 August, 2017As it gears up for the launch of its autism diagnostic test panel, US metabolomics company Stemina Biomarker Discovery has announced the appointment of Dr Heiner Dreismann to its board of directors.
'Stiffer' blood vessels may increase risk of heart attack
22 August, 2017Research led by Macquarie University has found that blood vessel 'stiffness', or distensibility, is an important determinant of blood flow, and may play a role in influencing the fate of Australians living with coronary heart disease.
Inadequate T-cell development linked to autoimmune diseases
18 August, 2017 by Adam FloranceResearchers have determined that mutations in the gene encoding a particular enzyme may help in the development of better treatments for a wide range of autoimmune diseases.
Tumour blood supply stopped in its tracks by dextran-catechin
10 August, 2017 by Adam FloranceAn international study, led by researchers from the Children's Cancer Institute and University of New South Wales, has uncovered a new way of dealing with neuroblastoma, a form of cancer that typically affects infants as young as one or two years of age.
